Alliancebernstein L.P. Athira Pharma, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.71 $14,627 - $19,663	5,300 Added 6.92%	81,900 $259,000
Q3 2022 Nov 15, 2022	BUY	$2.93 - $3.96 $28,421 - $38,412	9,700 Added 14.5%	76,600 $228,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $40,278 - $197,421	14,700 Added 28.16%	66,900 $204,000
Q1 2022 May 13, 2022	SELL	$8.96 - $13.51 $23,296 - $35,126	-2,600 Reduced 4.74%	52,200 $705,000
Q2 2021 Jul 30, 2021	BUY	$10.24 - $20.87 $561,152 - $1.14 Million	54,800 New	54,800 $561,000

16.8M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $18.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.